Ruairi J Mackenzie
Senior Science Writer
As senior science writer, Ruairi pens and edits scientific news, articles and features, with a focus on the complexities and curiosities of the brain and emerging informatics technologies. Ruairi also drives Technology Networks' search engine optimization (SEO) and editorial AI strategy and created the site’s podcast, Opinionated Science, in 2020. Ruairi has a Master’s degree in Clinical Neurosciences from the University of Cambridge.
Latest Content
News
Jellyfish Have No Brain But Are Able To Learn From Experience
New research shows for the first time that despite lacking a central brain, jellyfish can still learn from their environment and change their behavior accordingly. The study is published in Current Biology.
News
A Mother’s Body Retains Cells From Her Child After Pregnancy
Pregnancy changes the human body dramatically. One of the smallest alterations that pregnancy produces may also be the most important, suggests new research exploring cell populations passed between mother and child.
News
Circadian Clock Study Shows Why Jet Lag Wipes Us Out
New research has modeled the interactions between our body’s circadian clocks to investigate why jet lag leaves us so fatigued.
News
World's First Case of Human Brain Infection by a Python Roundworm Identified
Researchers from the Australian National University (ANU) and Canberra Hospital have reported the first-ever case of a human infected with a parasitic roundworm originating from a carpet python.
Industry Insight
Exploring the LSD-Derivative With Potential for Treating Mood Disorders
BetterLife Pharma’s lead candidate is a non-hallucinogenic derivative of LSD that mimics the projected therapeutic properties of LSD. To learn more, we spoke with BetterLife Pharma’s chief operating officer, Dr. Hooshmand Sheshbaradaran, and head of preclinical research, Dr. Abdi Ghaffari.
News
Single Psilocybin Dose Once Again Found To Relieve Major Depression
A new clinical trial has reaffirmed the potential of the magic mushroom-derived compound psilocybin to relieve the symptoms of major depression. The study, published in the Journal of the American Medical Association, is the latest to suggest that psychedelic drugs can provide a new treatment option in psychiatry.
News
21 Days in a Weightless Bed Can Affect the Body Like a Trip to Space
A study suggests that some changes the body undergoes during a trip to space can also happen after a few weeks of weightlessness on Earth.
News
Paralyzed Patients Speak Again Thanks to AI-Powered Brain Implants
Efforts to restore speech to people silenced by brain injuries and diseases have taken a significant step forward with the publication of two new papers in the journal Nature.
Industry Insight
Non-Hallucinogenic Drug Inspired by Psychedelics Enters First-in-Human Study
To learn more about the progress and development of non-hallucinogenic psychedelic therapies for conditions such as depression, Technology Networks spoke with the head of research and development at Delix Therapeutics, Dr. Eliseo Salinas.
News
Breakthrough in Brain Rejuvenation Identifies Anti-Aging Plasma Factor
Researchers have long known that the anti-aging hormone klotho, infusions of blood from younger animals and exercise can boost the brain function of aging mice. The underlying mechanism behind these changes has remained elusive until now.
Advertisement
